{"id":4815,"date":"2012-06-18T09:00:00","date_gmt":"2012-06-18T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/"},"modified":"2024-09-23T11:22:45","modified_gmt":"2024-09-23T11:22:45","slug":"onderzoek-naar-diaprep277-wordt-gestimuleerd","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/","title":{"rendered":"Onderzoek naar DiaPrep277 wordt gestimuleerd"},"content":{"rendered":"<p>Het gaat goed met de ontwikkeling van middelen op basis van DiaPep277. Ter bevestiging van eerdere resultaten is een wereldwijd fase 3 klinisch onderzoek gaande en in de VS heeft de FDA aan het middel de zogenaamde Orphan Drug status toegekend. Hierdoor krijgen de ontwikkelende bedrijven voor een zekere periode aanzienlijke voordelen op de Amerikaanse markt. <\/p>\n<div><a href=\"http:\/\/asweetlife.org\/a-sweet-life-staff\/in-the-news\/type-1-in-the-news\/diapep277-granted-orphan-drug-designation-by-fda\/27604\/\"> Lees verder (Engelstalig)<\/a><\/div>","protected":false,"raw":""},"excerpt":{"rendered":"<p>Het gaat goed met de ontwikkeling van middelen op basis van DiaPep277. Ter bevestiging van eerdere resultaten is een wereldwijd fase 3 klinisch onderzoek gaande en in de VS heeft de FDA aan het middel de zogenaamde Orphan Drug status toegekend. Hierdoor krijgen de ontwikkelende bedrijven voor een zekere periode aanzienlijke voordelen op de Amerikaanse [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184,189,195],"tags":[],"class_list":["post-4815","post","type-post","status-publish","format-standard","hentry","category-archief","category-betacelregeneratie","category-voorkomen"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Onderzoek naar DiaPrep277 wordt gestimuleerd - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Onderzoek naar DiaPrep277 wordt gestimuleerd - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Het gaat goed met de ontwikkeling van middelen op basis van DiaPep277. Ter bevestiging van eerdere resultaten is een wereldwijd fase 3 klinisch onderzoek gaande en in de VS heeft de FDA aan het middel de zogenaamde Orphan Drug status toegekend. Hierdoor krijgen de ontwikkelende bedrijven voor een zekere periode aanzienlijke voordelen op de Amerikaanse [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2012-06-18T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:45+00:00\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Onderzoek naar DiaPrep277 wordt gestimuleerd\",\"datePublished\":\"2012-06-18T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/\"},\"wordCount\":63,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"articleSection\":[\"Archief\",\"B\u00e8tacelregeneratie\",\"Voorkomen\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/\",\"name\":\"Onderzoek naar DiaPrep277 wordt gestimuleerd - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"datePublished\":\"2012-06-18T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Onderzoek naar DiaPrep277 wordt gestimuleerd\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Onderzoek naar DiaPrep277 wordt gestimuleerd - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/","og_locale":"nl_NL","og_type":"article","og_title":"Onderzoek naar DiaPrep277 wordt gestimuleerd - Breakthrough T1D","og_description":"Het gaat goed met de ontwikkeling van middelen op basis van DiaPep277. Ter bevestiging van eerdere resultaten is een wereldwijd fase 3 klinisch onderzoek gaande en in de VS heeft de FDA aan het middel de zogenaamde Orphan Drug status toegekend. Hierdoor krijgen de ontwikkelende bedrijven voor een zekere periode aanzienlijke voordelen op de Amerikaanse [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/","og_site_name":"Breakthrough T1D","article_published_time":"2012-06-18T09:00:00+00:00","article_modified_time":"2024-09-23T11:22:45+00:00","author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Onderzoek naar DiaPrep277 wordt gestimuleerd","datePublished":"2012-06-18T09:00:00+00:00","dateModified":"2024-09-23T11:22:45+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/"},"wordCount":63,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"articleSection":["Archief","B\u00e8tacelregeneratie","Voorkomen"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/","name":"Onderzoek naar DiaPrep277 wordt gestimuleerd - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"datePublished":"2012-06-18T09:00:00+00:00","dateModified":"2024-09-23T11:22:45+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/onderzoek-naar-diaprep277-wordt-gestimuleerd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Onderzoek naar DiaPrep277 wordt gestimuleerd"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/4815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=4815"}],"version-history":[{"count":1,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/4815\/revisions"}],"predecessor-version":[{"id":7289,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/4815\/revisions\/7289"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=4815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=4815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=4815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}